Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents

被引:3
|
作者
Cholankeril, G. [1 ]
Yoo, E. R. [2 ]
Hu, M. [3 ]
Gadiparthi, C. [1 ]
Khan, M. A. [1 ]
Perumpail, R. B. [4 ]
Bonham, C. A. [5 ]
Ahmed, A. [4 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Div Gastroenterol & Hepatol, Memphis, TN 38163 USA
[2] Univ Illinois, Coll Med, Dept Med, Chicago, IL USA
[3] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA
[4] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA
[5] Stanford Univ, Sch Med, Dept Surg, Div Abdominal Transplantat, Stanford, CA 94305 USA
关键词
direct-acting antiviral; hepatitis C virus; liver transplantation; retransplantation; HEPATITIS-C; INFECTION;
D O I
10.1111/jvh.12750
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1194 / 1195
页数:2
相关论文
共 50 条